Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments - Narrative (Details)

v3.22.2.2
Fair Value of Financial Instruments - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]        
Unrealized gain (loss) included in OCI $ 0   $ 0  
Specialty Chemicals        
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]        
Asset impairments   $ 200,000   $ 200,000